Table 2.
Medical Condition | Therapeutic Regimen | Clinical Endpoint | Outcome | Study Type | Reference |
---|---|---|---|---|---|
Major trauma from road traffic accident | An amount of 10 mg/kg every 8 h for two weeks in a multimodal analgesic regimen | Managing chronic neuropathic pain | Beneficial | Case report (n = 2) |
[42] |
Musculoskeletal injuries and trauma | An amount of 6.5 mg/kg every 12 h up to 12 months initially as adjunctive therapy and then as single analgesic at home | Managing chronic neuropathic pain | Beneficial | Case report (n = 3) |
[41] |
Postoperative pain after ovariohysterectomy | An amount of 50 mg, administered 12 h and 1 h before surgery in combination with buprenorphine | Managing postoperative pain | Beneficial | Randomized, placebo-controlled, masked trial (n = 52) | [18] |
Osteoarthritis | An amount of 10 mg/kg every 12 h for two weeks | Managing chronic pain | Beneficial, sedation as unique side effect | Randomized, cross-over, placebo-controlled, masked trial (n = 20) | [40] |
Osteoarthritis and dental disease | An amount of 10 mg/kg every 8 h for five days (transdermal route) |
Managing chronic pain | Beneficial | Prospective clinical trial (n = 15) | [78] |
Discospondylitis-related chronic neuropathic pain | Not reported | Managing chronic neuropathic pain | Not reported | Retrospective clinical trial (n = 17) | [85] |
Thermal antinociceptive threshold test | Amounts of 5, 10, and 30 mg/kg, single administration | Determination of the thermal antinociceptive effect of various single doses | Non beneficial | Randomized, cross-over, placebo-controlled, masked trial (n = 6) | [79] |
Anxiety and fear | An amount of 9.2–47.6 mg/kg, single administration | To create a fear-free veterinary visits | Beneficial | Randomized, placebo-controlled, double-blinded trial (n = 53) | [19] |
Anxiety and fear | An amount of 13.0–29.4 mg/kg, single administration 90 min prior to placing the cat into the carrier | To create a fear-free veterinary visits | Beneficial | Randomized, cross-over, placebo-controlled, masked trial (n = 20) | [20] |
Anxiety and fear | An amount of 100 mg/cat ≤ 4 kg, 150 mg/cat ≥ 4.1 kg, single administration 30 min before the visit | To create a fear-free veterinary visits and provoke mild sedation to execute an hemodynamical and cardiological evaluation | Beneficial | Randomized, cross-over, placebo-controlled, double-blinded trial (n = 10) | [22] |
Anxiety and fear | An amount of 20 mg/kg, single administration 1 h prior to leaving home | To evaluate the efficacy of gabapentin as an anxiolytic in hyperthyroid patients | Beneficial | Randomized, placebo-controlled, double-blinded trial (n = 10) | [21] |
Healthy cats undergoing ovariectomy | An amount of 5 mg/kg, two administrations after surgery, during an 8 h observation period | Evaluation of the appetite-stimulating effect | Beneficial | Randomized, placebo-controlled, double-blinded trial (n = 60) | [17] |